about
Identification and characterization of ovarian cancer-initiating cells from primary human tumorsDistinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant casePutative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cellsPromoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.Growth inhibition of ovarian tumor-initiating cells by niclosamide.FT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancerA mathematical model of bimodal epigenetic control of miR-193a in ovarian cancer stem cellsAberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancerDNA methylation profiles and biomarkers of oral squamous cell carcinoma.High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma.Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.Guizhi Fuling Wan as a novel agent for intravesical treatment for bladder cancer in mouse model.Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer.Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients.TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy.NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1α expression.Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.Hard clam extracts induce atypical apoptosis in human gastric cancer cells.Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways.Aberrant epigenetic modifications in radiation-resistant head and neck cancers.Global profiling of histone modifications in the polyomavirus BK virion minichromosome.Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation.Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.Hemolytic E. coli Promotes Colonic Tumorigenesis in Females.Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a population-based surgical cohort studyDNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer.Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.Oncogene-tumor suppressor gene feedback interactions and their control.Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer.Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cellsAberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogrammingZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancerE2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemnessMethylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
P50
Q24644329-5341309E-D2D6-499E-A50A-F516AEB840E9Q31014123-B05033E2-0DDA-4E32-99FC-46249733A5F4Q33590673-C8AB1EBC-BCA1-44B5-B824-69C2C2A0725CQ33594982-55BF90ED-99A6-4A27-84DA-C7B7C0B61E1AQ33934590-9AF4A884-5550-4311-A9F3-C0830285AFE0Q34161719-E9A56CE8-3CCB-4C73-AD64-0E050ABECAB5Q34265703-5783B8C3-90B9-470B-BB74-86CDF9A2A6B2Q34486707-0A3D1DA8-F266-4EAE-8526-470D072421B2Q34784456-CD731A08-D788-47E8-A454-E189D3A36E9EQ35985483-829F0294-D9C6-48B2-9022-65A65F824F8EQ36213267-D885270C-5BEF-4C7E-BDD6-D4E7FADA4AA2Q36244287-86A86FC5-0644-4F01-BFA7-819C7952A462Q36557362-2C884A56-1EC4-4DF5-B7C9-D1B8FD06C605Q37177069-749E4658-E8B1-4465-BD29-A151860BFA6DQ37216997-00E367BE-7966-465B-A25C-892EEE6C82DFQ37286432-E490FCC6-482A-4994-BE4E-5423A6149734Q37619308-50835DA1-B6E1-434A-AADD-BF6E05FC607DQ37798252-4F6C9FBB-833D-49AB-8DE0-D623DBAF0A4DQ38304336-46446FEC-2790-4C79-AFF9-50AA35411E9FQ38316206-23D488D7-B98A-4B5F-A4A0-AF218216B3CAQ38642150-BDCA0FB4-E1F2-4E3B-BAD8-B77737CED551Q38828996-DE2CFE94-9C5F-4A77-9E62-F456B9678A20Q38938064-2E27E601-13B5-44DD-80F5-0EDF79324AEFQ39009104-E16EA069-3D08-402D-B29B-95BB201B1BF7Q39020798-24091401-6671-4C4C-9ED4-39FF7E8D6536Q39923052-6A19989E-5262-4524-9C71-13F692CCC8B9Q40358931-403D25B4-359F-4372-8428-251BC2D690CEQ40741561-7091965D-2EC7-4542-8531-0EBF2CF47C63Q42267544-A004A7EE-72EF-495A-89E0-B6F9249D68ABQ42361143-F4E470DA-2826-49B6-BD87-D7A52B21546AQ44226862-F6D18D69-6335-446E-992C-2FC9EEBA4C4DQ47788273-2FAA0619-2F89-490F-AC40-CBD0AC62FBD6Q50733311-23D9A115-C9A7-43C1-8BFA-DAB5AB57A096Q51509506-8A66C514-89E5-4764-9683-273F861173CEQ53263431-A9CB7F1A-5F8E-42EB-A080-21C96D1909C6Q57176040-F8A28C3D-310C-425C-8986-11BB5B146940Q60907348-0C4AD267-ED1A-47C0-8F10-DF0F814E6C53Q64236612-3F7C1662-9BD6-4987-9171-3E6A7B6ED121Q64236657-A1FC55DF-CD80-4CF9-AE4E-3DDAE2E84285Q64974815-6AD7620C-C2E1-42FC-BDEC-4947B81F8D11
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael W Chan
@nl
Michael W Chan
@sl
Michael W. Chan
@en
Michael W. Chan
@es
type
label
Michael W Chan
@nl
Michael W Chan
@sl
Michael W. Chan
@en
Michael W. Chan
@es
prefLabel
Michael W Chan
@nl
Michael W Chan
@sl
Michael W. Chan
@en
Michael W. Chan
@es
P106
P1153
7402597788
P31
P496
0000-0003-1431-322X